| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.39 | 0.06 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.06 |